US 9464035
Salicylic acid derivatives useful as glucocerebrosidase activators
granted A61PA61P25/16A61P25/28
Quick answer
US patent 9464035 (Salicylic acid derivatives useful as glucocerebrosidase activators) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/16, A61P25/28, A61P3/00, A61P43/00